Aptevo Therapeutics Ownership 2024 | Who Owns Aptevo Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

15.37%

Insider Ownership

0.06%

Retail Ownership

84.57%

Institutional Holders

30.00

Aptevo Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-1,897	-100.00%	-	Mar 31, 2024
FIFTH THIRD BANCORP	-	-	-	-291	-100.00%	-	Mar 31, 2024
FRANKLIN RESOURCES INC	-	-	-	-10,997	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-6	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-1,617	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-14,121	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-10,941	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-91,725	-100.00%	-	Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-142	-100.00%	-	Mar 31, 2024
CITIGROUP INC	-	-	-	-10	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-11,370	-100.00%	-	Mar 31, 2024
CANTOR FITZGERALD, L. P.	-	-	-	-58,532	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-516,789	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-43,201	-100.00%	-	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-104,608	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-46,635	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-262,124	-100.00%	-	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-11,248	-100.00%	-	Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.	-	-	-	-45,980	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,660	-100.00%	-	Mar 31, 2024

Aptevo Therapeutics's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-1,897	-100.00%	-	Mar 31, 2024
FIFTH THIRD BANCORP	-	-	-	-291	-100.00%	-	Mar 31, 2024
FRANKLIN RESOURCES INC	-	-	-	-10,997	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-6	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-1,617	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-14,121	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-10,941	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-91,725	-100.00%	-	Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-142	-100.00%	-	Mar 31, 2024
CITIGROUP INC	-	-	-	-10	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-11,370	-100.00%	-	Mar 31, 2024
CANTOR FITZGERALD, L. P.	-	-	-	-58,532	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-516,789	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-43,201	-100.00%	-	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-104,608	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-46,635	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-262,124	-100.00%	-	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-11,248	-100.00%	-	Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.	-	-	-	-45,980	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,660	-100.00%	-	Mar 31, 2024

The largest Aptevo Therapeutics shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Aptevo Therapeutics (APVO), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	-	-	-	-5	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-6	-100.00%	-	Mar 31, 2024
CITIGROUP INC	-	-	-	-10	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-17	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30	-100.00%	-	Mar 31, 2024
TRUVESTMENTS CAPITAL LLC	-	-	-	-95	-100.00%	-	Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-142	-100.00%	-	Mar 31, 2024
FIFTH THIRD BANCORP	-	-	-	-291	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-1,617	-100.00%	-	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	-	-1,897	-100.00%	-	Mar 31, 2024
DIVERGENT WEALTH ADVISORS	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-10,941	-100.00%	-	Mar 31, 2024
FRANKLIN RESOURCES INC	-	-	-	-10,997	-100.00%	-	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-11,248	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-11,370	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,660	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-14,121	-100.00%	-	Mar 31, 2024
BAADER BANK AKTIENGESELLSCHAFT	-	-	-	-15,086	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-43,201	-100.00%	-	Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.	-	-	-	-45,980	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Aptevo Therapeutics's largest institutional buyer is UBS GROUP AG. The company purchased -5.00 stocks of APVO, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-516,789	-100.00%	-	Mar 31, 2024
SABBY MANAGEMENT, LLC	-	-	-	-349,471	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-262,124	-100.00%	-	Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC	-	-	-	-159,000	-100.00%	-	Mar 31, 2024
SQUAREPOINT OPS LLC	-	-	-	-138,697	-100.00%	-	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-104,608	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-91,725	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-61,130	-100.00%	-	Mar 31, 2024
CANTOR FITZGERALD, L. P.	-	-	-	-58,532	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-46,635	-100.00%	-	Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.	-	-	-	-45,980	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-43,201	-100.00%	-	Mar 31, 2024
BAADER BANK AKTIENGESELLSCHAFT	-	-	-	-15,086	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-14,121	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,660	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-11,370	-100.00%	-	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-11,248	-100.00%	-	Mar 31, 2024
FRANKLIN RESOURCES INC	-	-	-	-10,997	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-10,941	-100.00%	-	Mar 31, 2024
DIVERGENT WEALTH ADVISORS	-	-	-	-10,000	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Aptevo Therapeutics's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -0.52M shares of APVO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-516,789	-100.00%	-	Mar 31, 2024
SABBY MANAGEMENT, LLC	-	-	-	-349,471	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-262,124	-100.00%	-	Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC	-	-	-	-159,000	-100.00%	-	Mar 31, 2024
SQUAREPOINT OPS LLC	-	-	-	-138,697	-100.00%	-	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-104,608	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-91,725	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-61,130	-100.00%	-	Mar 31, 2024
CANTOR FITZGERALD, L. P.	-	-	-	-58,532	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-46,635	-100.00%	-	Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.	-	-	-	-45,980	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-43,201	-100.00%	-	Mar 31, 2024
BAADER BANK AKTIENGESELLSCHAFT	-	-	-	-15,086	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-14,121	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,660	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-11,370	-100.00%	-	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-11,248	-100.00%	-	Mar 31, 2024
FRANKLIN RESOURCES INC	-	-	-	-10,997	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-10,941	-100.00%	-	Mar 31, 2024
DIVERGENT WEALTH ADVISORS	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	-	-1,897	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-1,617	-100.00%	-	Mar 31, 2024
FIFTH THIRD BANCORP	-	-	-	-291	-100.00%	-	Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-142	-100.00%	-	Mar 31, 2024
TRUVESTMENTS CAPITAL LLC	-	-	-	-95	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-17	-100.00%	-	Mar 31, 2024
CITIGROUP INC	-	-	-	-10	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-6	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-5	-100.00%	-	Mar 31, 2024

Aptevo Therapeutics's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.52M shares, valued at -, as of undefined.

Aptevo Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.03%	83,802	-	-	Dec 29, 2023
T. Rowe Price Index Trust, Inc.	0.00%	46,200	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	183,450	-37,614	-17.01%	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	41,777	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	2,287	-	-	Dec 31, 2023
SCHWAB CAPITAL TRUST	0.00%	1,654	-	-	Feb 29, 2024
Legg Mason Global Asset Management Trust	0.00%	13,113	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	6,015	-	-	Jan 31, 2024
Legg Mason Global Asset Management Trust	0.00%	10,288	-	-	Jan 31, 2024
NORTHERN FUNDS	0.00%	5,531	-	-	Dec 29, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	3,470	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	709	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	524	-	-	Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	400	-	-	Dec 31, 2023

Aptevo Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 83.80K shares, compromising 0.03% of its total assets.

Aptevo Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	30	15.38%
30 Sep, 23	26	13.04%
30 Jun, 23	23	-
31 Mar, 23	23	-11.54%
31 Dec, 22	26	30.00%
30 Sep, 22	20	-
30 Jun, 22	20	17.65%
31 Mar, 22	17	-5.56%
31 Dec, 21	18	-14.29%
30 Sep, 21	21	-16.00%
30 Jun, 21	25	-24.24%
31 Mar, 21	33	-2.94%
31 Dec, 20	34	100.00%
30 Sep, 20	17	-10.53%
30 Jun, 20	19	18.75%
31 Mar, 20	16	-

As of 31 Dec 23, 30 institutions are holding Aptevo Therapeutics's shares, representing an increase of 15.38% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	1,933,445	-43.29%
30 Sep, 23	3,409,316	267.07%
30 Jun, 23	928,804	5.35%
31 Mar, 23	881,596	-8.48%
31 Dec, 22	963,250	11.08%
30 Sep, 22	867,149	9.03%
30 Jun, 22	795,337	0.40%
31 Mar, 22	792,190	4.13%
31 Dec, 21	760,799	-75.57%
30 Sep, 21	3,114,105	5.20%
30 Jun, 21	2,960,222	0.56%
31 Mar, 21	2,943,853	1.18%
31 Dec, 20	2,909,605	341.29%
30 Sep, 20	659,348	4.30%
30 Jun, 20	632,184	30.45%
31 Mar, 20	484,601	-

Aptevo Therapeutics (APVO) has 1.93M shares outstanding as of 31 Dec 23, down -43.29% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	15.37%	0.56%
30 Sep, 23	52.60%	30.06%
30 Jun, 23	13.23%	8.39%
31 Mar, 23	12.55%	3.52%
31 Dec, 22	18.89%	6.51%
30 Sep, 22	17.03%	6.80%
30 Jun, 22	15.83%	6.15%
31 Mar, 22	16.04%	6.09%
31 Dec, 21	16.23%	0.40%
30 Sep, 21	63.66%	1.50%
30 Jun, 21	65.25%	1.47%
31 Mar, 21	66.63%	1.54%
31 Dec, 20	65.85%	15.83%
30 Sep, 20	20.40%	5.33%
30 Jun, 20	19.56%	8.90%
31 Mar, 20	14.82%	-

As of 31 Dec 23, Aptevo Therapeutics is held by 15.37% institutional shareholders, representing a 0.56% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	12	33.33%
30 Sep, 23	9	50.00%
30 Jun, 23	6	-14.29%
31 Mar, 23	7	-46.15%
31 Dec, 22	13	44.44%
30 Sep, 22	9	-
30 Jun, 22	9	50.00%
31 Mar, 22	6	-25.00%
31 Dec, 21	8	-20.00%
30 Sep, 21	10	-23.08%
30 Jun, 21	13	-13.33%
31 Mar, 21	15	-44.44%
31 Dec, 20	27	237.50%
30 Sep, 20	8	-11.11%
30 Jun, 20	9	-43.75%
31 Mar, 20	16	-

12 institutional shareholders have increased their position in APVO stock as of 31 Dec 23 compared to 9 in the previous quarter (a 33.33% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	7	40.00%
30 Sep, 23	5	150.00%
30 Jun, 23	2	-60.00%
31 Mar, 23	5	-37.50%
31 Dec, 22	8	166.67%
30 Sep, 22	3	-57.14%
30 Jun, 22	7	16.67%
31 Mar, 22	6	50.00%
31 Dec, 21	4	33.33%
30 Sep, 21	3	-25.00%
30 Jun, 21	4	-66.67%
31 Mar, 21	12	200.00%
31 Dec, 20	4	-20.00%
30 Sep, 20	5	-
30 Jun, 20	5	-
31 Mar, 20	-	-

7 institutional shareholders have reduced their position in APVO stock as of 31 Dec 23 compared to 5 in the previous quarter (a 40.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	30	15.38%	1,933,445	-43.29%	15.37%	0.56%	12	33.33%	7	40.00%
30 Sep, 23	26	13.04%	3,409,316	267.07%	52.60%	30.06%	9	50.00%	5	150.00%
30 Jun, 23	23	-	928,804	5.35%	13.23%	8.39%	6	-14.29%	2	-60.00%
31 Mar, 23	23	-11.54%	881,596	-8.48%	12.55%	3.52%	7	-46.15%	5	-37.50%
31 Dec, 22	26	30.00%	963,250	11.08%	18.89%	6.51%	13	44.44%	8	166.67%
30 Sep, 22	20	-	867,149	9.03%	17.03%	6.80%	9	-	3	-57.14%
30 Jun, 22	20	17.65%	795,337	0.40%	15.83%	6.15%	9	50.00%	7	16.67%
31 Mar, 22	17	-5.56%	792,190	4.13%	16.04%	6.09%	6	-25.00%	6	50.00%
31 Dec, 21	18	-14.29%	760,799	-75.57%	16.23%	0.40%	8	-20.00%	4	33.33%
30 Sep, 21	21	-16.00%	3,114,105	5.20%	63.66%	1.50%	10	-23.08%	3	-25.00%
30 Jun, 21	25	-24.24%	2,960,222	0.56%	65.25%	1.47%	13	-13.33%	4	-66.67%
31 Mar, 21	33	-2.94%	2,943,853	1.18%	66.63%	1.54%	15	-44.44%	12	200.00%
31 Dec, 20	34	100.00%	2,909,605	341.29%	65.85%	15.83%	27	237.50%	4	-20.00%
30 Sep, 20	17	-10.53%	659,348	4.30%	20.40%	5.33%	8	-11.11%	5	-
30 Jun, 20	19	18.75%	632,184	30.45%	19.56%	8.90%	9	-43.75%	5	-
31 Mar, 20	16	-	484,601	-	14.82%	-	16	-	-	-

Aptevo Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 05, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Sell	3,667	-	-	7,333
Mar 05, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Sell	1,584	-	-	1,583
Mar 05, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Sell	5,500	-	-	11,000
Mar 05, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Sell	3,667	-	-	3,667
Mar 05, 2024	Kwon SoYoung	officer	SVP, GC, BD & Corp Affairs	M-Exempt	Sell	3,667	-	-	7,333
Mar 05, 2024	Kwon SoYoung	officer	SVP, GC, BD & Corp Affairs	M-Exempt	Sell	3,667	-	-	3,667
Mar 05, 2024	White Marvin L	director, officer	President and CEO	M-Exempt	Sell	12,917	-	-	25,833
Mar 05, 2024	White Marvin L	director, officer	President and CEO	M-Exempt	Sell	9,584	-	-	9,584
Jan 30, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Sell	792	-	-	-
Jan 30, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Sell	1,833	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 05, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Buy	1,584	-	$1.58	18,411
Mar 05, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Buy	3,667	-	$3.67	16,827
Mar 05, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Sell	3,667	-	-	7,333
Mar 05, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Sell	1,584	-	-	1,583
Mar 05, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Buy	3,667	-	$3.67	37,504
Mar 05, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Buy	5,500	-	$5.50	33,837
Mar 05, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Sell	5,500	-	-	11,000
Mar 05, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Sell	3,667	-	-	3,667
Mar 05, 2024	Kwon SoYoung	officer	SVP, GC, BD & Corp Affairs	M-Exempt	Buy	3,667	-	$3.67	24,042
Mar 05, 2024	Kwon SoYoung	officer	SVP, GC, BD & Corp Affairs	M-Exempt	Buy	3,667	-	$3.67	20,375
Mar 05, 2024	Kwon SoYoung	officer	SVP, GC, BD & Corp Affairs	M-Exempt	Sell	3,667	-	-	7,333
Mar 05, 2024	Kwon SoYoung	officer	SVP, GC, BD & Corp Affairs	M-Exempt	Sell	3,667	-	-	3,667
Mar 05, 2024	White Marvin L	director, officer	President and CEO	M-Exempt	Buy	9,584	-	$9.58	67,430
Mar 05, 2024	White Marvin L	director, officer	President and CEO	M-Exempt	Buy	12,917	-	$12.92	57,846
Mar 05, 2024	White Marvin L	director, officer	President and CEO	M-Exempt	Sell	12,917	-	-	25,833
Mar 05, 2024	White Marvin L	director, officer	President and CEO	M-Exempt	Sell	9,584	-	-	9,584
Jan 30, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Buy	792	-	$0.79	13,160
Jan 30, 2024	Taylor Daphne	officer	SVP, CFO	M-Exempt	Sell	792	-	-	-
Jan 30, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Buy	1,833	-	$1.83	28,337
Jan 30, 2024	Lamothe Jeffrey G.	officer	EVP, COO	M-Exempt	Sell	1,833	-	-	-

The last insider sell of Aptevo Therapeutics's stock was made by Taylor Daphne on Mar 05 2024, selling 3,667 shares at - per share (valued at -).

Aptevo Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	11	11	100.00%
Q3 2023	9	9	100.00%
Q2 2023	11	6	183.33%
Q1 2023	14	12	116.67%
Q3 2022	9	-	-
Q2 2022	7	4	175.00%
Q1 2022	9	-	-
Q4 2021	3	17	17.65%
Q2 2021	14	-	-
Q1 2021	6	-	-
Q4 2020	16	-	-
Q3 2020	26	43	60.47%
Q1 2020	6	-	-
Q4 2019	6	-	-
Q3 2019	11	-	-
Q2 2019	15	-	-
Q1 2019	12	10	120.00%
Q4 2018	2	-	-
Q3 2018	1	20	5.00%
Q2 2018	7	2	350.00%

11 total buy trades, and 11 total sell trades (buy/sell ratio of 1.00%) were made by Aptevo Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	17	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	16	-	-
Q3 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	11	-	-
Q2 2019	9	-	-
Q1 2019	-	-	-
Q4 2018	2	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Aptevo Therapeutics's stocks.

Aptevo Therapeutics Peer Ownership

Ticker	Company
IVVD	Invivyd, Inc.
VRAX	Virax Biolabs Group Limited
QNRX	Quoin Pharmaceuticals, Ltd.
HOTH	Hoth Therapeutics, Inc.
MGTA	Dianthus Therapeutics, Inc.
PASG	Passage Bio, Inc.
NTRB	Nutriband Inc.
LGVN	Longeveron Inc.
RNXT	RenovoRx, Inc.
TCON	TRACON Pharmaceuticals, Inc.
REVB	Revelation Biosciences, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
LRMR	Larimar Therapeutics, Inc.
CYCN	Cyclerion Therapeutics, Inc.
ACHL	Achilles Therapeutics plc
ATXI	Avenue Therapeutics, Inc.
ADXN	Addex Therapeutics Ltd
KRON	Kronos Bio, Inc.

APVO Ownership FAQ

Who Owns Aptevo Therapeutics?

Aptevo Therapeutics is owned by institutional shareholders (15.37%), insiders (0.06%), and public (84.57%). The largest institutional shareholder of Aptevo Therapeutics is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.03% of total shares).

Who are the major institutional shareholders of Aptevo Therapeutics?

Aptevo Therapeutics's major institutional shareholders are JPMORGAN CHASE & CO, FIFTH THIRD BANCORP, FRANKLIN RESOURCES INC, BANK OF AMERICA CORP /DE/, and WELLS FARGO & COMPANY/MN. The top five shareholders own together 0% of the company's share outstanding.

How many Aptevo Therapeutics shareholders are there?

As of Dec 2023, there are 30 institutional shareholders of Aptevo Therapeutics.

What percentage of Aptevo Therapeutics is owned by JPMORGAN CHASE & CO?

JPMORGAN CHASE & CO owns 0 shares of Aptevo Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

What percentage of Aptevo Therapeutics is owned by FIFTH THIRD BANCORP?

As of Mar 2024, FIFTH THIRD BANCORP holds 0 shares of Aptevo Therapeutics (APVO), compromising 0% of the company, valued at $0.

What percentage of Aptevo Therapeutics is owned by FRANKLIN RESOURCES INC?

FRANKLIN RESOURCES INC is the third largest holder of Aptevo Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).